XWELL, Inc.
NCM: XWELLive Quote
📈 ZcoreAI Score
Our AI model analyzes XWELL, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get XWEL Z-Score →About XWELL, Inc.
Healthcare
Diagnostics & Research
XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
📊 Fundamental Analysis
XWELL, Inc. demonstrates a profit margin of -58.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported -4.2% revenue growth, which is negative, indicating a recent decline in revenue.
At a current price of $1.19, XWEL currently sits at the 48th percentile of its 52-week range (Range: $0.26 - $2.20).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Revenue Growth
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$9.43M
Trailing P/E
--
Forward P/E
-0.45
Beta (5Y)
0.96
52W High
$2.20
52W Low
$0.26
Avg Volume
8.98M
Day High
Day Low